STSS

Sharps Technology, Inc. (STSS) is a medical device company that designs, researches, develops, manufactures, and commercializes safety syringe products in the United States. The company offers ultra-low waste syringes with safety and reuse prevention features, as well as develops prefillable syringe systems. Here is a comprehensive analysis of STSS:

1. Technical Analysis:
- The closing price of STSS on the last trading day was $0.214, the resistance level was $0.238, and the support level was $0.190.
- The 5-day moving average was $0.269, the 10-day moving average was $0.284, and the 50-day moving average was $0.437.
- The Bollinger Bands were at 0.29, indicating a narrow trading range.
- The RSI was 27.45, which is considered oversold and may suggest a potential reversal or bounce-back in the stock price.
- The MACD was -0.02, and the KDJ was 9.72, both of which are relatively low and could indicate a stock that is currently oversold.
- The stock is trading within the Bollinger Bands, which typically suggests a consolidation phase.

|Ticker|Name|Support Level|Resistance Level|Closing Price|Date|code|market_code|
|---|---|---|---|---|---|---|---|
|STSS.O|Sharps Technology|0.2273|0.2468|0.2317|20240703|STSS|186|

|Ticker|Name|50-Day Moving Average|5-Day Moving Average|10-Day Moving Average|Date|code|market_code|
|---|---|---|---|---|---|---|---|
|STSS.O|Sharps Technology|0.2817|0.2367|0.2518|20240703|STSS|186|

|Ticker|Name|RSI|MACD|KDJ|Boll|Date|code|market_code|
|---|---|---|---|---|---|---|---|---|
|STSS.O|Sharps Technology|27.4510||9.7208|0.2907|20240702|STSS|186|
|STSS.O|Sharps Technology||-0.0178|||20240703|STSS|186|

2. Fundamental Analysis:
- The company has a negative ROE of -102.86% as of the end of Q1 2024, indicating that it is not generating positive returns on equity.
- The net income was -$982,386, and the gross margin was -13.28% as of the end of Q1 2024.
- The company does not pay dividends and has a negative EPS of -$0.05.
- The total revenue for the quarter ending March 31, 2024, was $0.003B.

|Ticker|Name|Total Revenue|ROE(Average)|Net Income|Gross Profit Margin|Dividend Yield (TTM)|Diluted EPS|Date|code|market_code|
|---|---|---|---|---|---|---|---|---|---|---|
|STSS.O|Sharps Technology||-13.28|-982386|||-0.05|20240331|STSS|186|
|STSS.O|Sharps Technology|||||||20240703|STSS|186|

3. Market Sentiment and News:
- The stock has experienced high volatility, with a wide range between its highest and lowest prices.
- There is a bearish sentiment, with expectations of a further fall within the current trend.
- However, there is also a bullish sentiment, with a buy signal issued from a pivot bottom point.
- The stock is currently undervalued according to one analysis, with a forecasted price of $0.269 for June 2, 2024.
4. Competitiveness and Business Outlook:
- Sharps Technology is facing competition in the medical device industry, as indicated by the high number of companies in the sector.
- The company has secured a significant purchase order for its syringes, which could be a positive sign for future revenue.
- The company's financials show a consistent decline in net income and gross margin over the past few years.
5. Stock Performance and Forecasts:
- The stock has experienced a 12.73% gain in the last trading day before July 1, 2024.
- The average one-year price target for STSS is $16.32, with forecasts ranging from a low of $16.16 to a high of $16.80.
- The stock is not suited for new portfolio additions due to its current bear market status.

In conclusion, STSS is a medical device company with a negative financial outlook, as indicated by its negative net income, gross margin, and ROE. The stock is currently trading in a narrow range and is considered oversold, which may suggest a potential reversal or bounce-back. However, the bearish sentiment and the company's financial performance indicate caution. Investors should consider these factors and monitor the stock closely for any signs of improvement or further declines.